Patients were assigned to one of two vaccine schedules to assess the feasibility of vaccination a sexually transmitted disease clinic population against hepatitis B virus.
Of 1386 patients entering an inner-city clinic between June and July 1990,611 (44%) accepted a first dose of vaccine.
Twenty-one percent of all susceptible patients received at least two doses of vaccine.
Annualizing these findings shows that an ongoing program could prevent 636 hepatitis B virus infections per year.
Although a significant proportion of sexually transmitted disease clinic patients can be successfully vaccinated, strategies for preventing hepatitis B virus infections in this high-risk population must consider patient behavior as well as vaccine efficacy.
Mots-clés Pascal : Hépatite virale B, Virose, Infection, Vaccination, Prévention, Homme, Programme sanitaire, Analyse coût, Economie santé, Stratégie, Etude comparative, Etats Unis, Amérique du Nord, Amérique, Appareil digestif pathologie, Foie pathologie
Mots-clés Pascal anglais : Viral hepatitis B, Viral disease, Infection, Vaccination, Prevention, Human, Sanitary program, Cost analysis, Health economy, Strategy, Comparative study, United States, North America, America, Digestive diseases, Hepatic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0350851
Code Inist : 002B05C02G. Création : 01/03/1996.